Pain Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pain stocks.

Pain Stocks Recent News

Date Stock Title
Nov 19 JNJ Large caps in trouble? Key takeaways from Tommy Tuberville's latest trades
Nov 19 JNJ Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive
Nov 19 LQDA 3 US Growth Stocks With At Least 10% Insider Ownership
Nov 19 JNJ Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
Nov 19 JNJ J&J pill clears skin in two late-stage psoriasis studies
Nov 19 JNJ Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Nov 18 JNJ J&J unveils positive phase 3 results for icotrokinra for plaque psoriasis
Nov 18 JNJ Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results
Nov 18 JNJ Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript)
Nov 18 SNY FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
Nov 18 JNJ How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
Nov 18 JNJ Johnson & Johnson appoints CIO to lead business technology strategy
Nov 18 JNJ CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC
Nov 18 JNJ Eli Lilly follows J&J in suing Biden administration over 340B rebates
Nov 17 TIVC Tivic Health Systems Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$1.48 loss in 3Q 2023)
Nov 15 SNY How analysts are reacting to RFK Jr. as Trump's HHS pick
Nov 15 JNJ U.S. Pharma is largely immune from 'MAHA' impact: Wolfe
Nov 15 JNJ Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)
Nov 15 JNJ Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says
Nov 15 SNY FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
Pain

Pain is a distressing feeling often caused by intense or damaging stimuli. The International Association for the Study of Pain's widely used definition defines pain as "an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage"; however, due to it being a complex, subjective phenomenon, defining pain has been a challenge. In medical diagnosis, pain is regarded as a symptom of an underlying condition.
Pain motivates the individual to withdraw from damaging situations, to protect a damaged body part while it heals, and to avoid similar experiences in the future. Most pain resolves once the noxious stimulus is removed and the body has healed, but it may persist despite removal of the stimulus and apparent healing of the body. Sometimes pain arises in the absence of any detectable stimulus, damage or disease.Pain is the most common reason for physician consultation in most developed countries. It is a major symptom in many medical conditions, and can interfere with a person's quality of life and general functioning. Simple pain medications are useful in 20% to 70% of cases. Psychological factors such as social support, hypnotic suggestion, excitement, or distraction can significantly affect pain's intensity or unpleasantness. In some debates regarding physician-assisted suicide or euthanasia, pain has been used as an argument to permit people who are terminally ill to end their lives.

Browse All Tags